[
  {
    "ts": null,
    "headline": "Why Novo Nordisk Is A Strong Buy Despite Market Concerns",
    "summary": "Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO stock a buy.",
    "url": "https://finnhub.io/api/news?id=3122007dae2978956606ea7a5228db0ac0ef5a4180bc8ae0df8c2091a0d4e554",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740009540,
      "headline": "Why Novo Nordisk Is A Strong Buy Despite Market Concerns",
      "id": 132792928,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1156718067/image_1156718067.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO stock a buy.",
      "url": "https://finnhub.io/api/news?id=3122007dae2978956606ea7a5228db0ac0ef5a4180bc8ae0df8c2091a0d4e554"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant",
    "summary": "Johnson & Johnson may outshine AbbVie as a top defensive stock pick. Read how Ben Graham's framework evaluates each healthcare company.",
    "url": "https://finnhub.io/api/news?id=4234bf4767780486bd96ca740ab0e1dc50f57e2d79ba7f295ef0827bf35c4370",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739967970,
      "headline": "AbbVie Vs. Johnson & Johnson: Graham Would Prefer The Consumer Healthcare Giant",
      "id": 132790113,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2161348087/image_2161348087.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson may outshine AbbVie as a top defensive stock pick. Read how Ben Graham's framework evaluates each healthcare company.",
      "url": "https://finnhub.io/api/news?id=4234bf4767780486bd96ca740ab0e1dc50f57e2d79ba7f295ef0827bf35c4370"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys",
    "summary": "January hits new highs with $814 in dividend income, up 21% Y/Y. See how BDC investments drive growth toward $11,000 annual dividends.",
    "url": "https://finnhub.io/api/news?id=5455f567381019beddc413e7e5eb783a45482cdef95f6ee343bcfd391c577c6d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739952600,
      "headline": "My Dividend Stock Portfolio: New January Dividend Record - 100 Holdings With 14 Buys",
      "id": 132784079,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "January hits new highs with $814 in dividend income, up 21% Y/Y. See how BDC investments drive growth toward $11,000 annual dividends.",
      "url": "https://finnhub.io/api/news?id=5455f567381019beddc413e7e5eb783a45482cdef95f6ee343bcfd391c577c6d"
    }
  }
]